Cynata Therapeutics to Act as Core Partner in Australian Regenerative Therapy Manufacturing Initiative; Shares Up 3%

MT Newswires Live

2025/04/24

Cynata Therapeutics (ASX:CYP) said it will act as a core partner in the Solutions for Manufacturing Advanced Regenerative Therapies Cooperative Research Center (SMART CRC), which recently received Australian Government funding, according to a Thursday filing with the Australian bourse.

SMART CRC is a AU$238 million national initiative with over 60 industry, government, healthcare, universities, and research institute partners, the filing said.

The partners will now move to draft and execute formal agreements, per the filing.

Shares were up 3% in afternoon trade on Thursday.

Price (AUD): $0.20, Change: $+0.0050, Percent Change: +2.63%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2529617985"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2529617985\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2529617985?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-24 11:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2529617985","market":"hk","top_or_hot":-1,"title":"Cynata Therapeutics to Act as Core Partner in Australian Regenerative Therapy Manufacturing Initiative; Shares Up 3%","media":"MT Newswires Live","content":"<html><body><p> Cynata <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (ASX:CYP) said it will act as a core partner in the Solutions for Manufacturing Advanced Regenerative Therapies Cooperative Research Center (SMART CRC), which recently received Australian Government funding, according to a Thursday filing with the Australian bourse.</p><p>SMART CRC is a AU$238 million national initiative with over 60 industry, government, healthcare, universities, and research institute partners, the filing said.</p><p>The partners will now move to draft and execute formal agreements, per the filing.</p><p>Shares were up 3% in afternoon trade on Thursday.</p><p>Price (AUD): $0.20, Change: $+0.0050, Percent Change: +2.63%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cynata Therapeutics to Act as Core Partner in Australian Regenerative Therapy Manufacturing Initiative; Shares Up 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCynata Therapeutics to Act as Core Partner in Australian Regenerative Therapy Manufacturing Initiative; Shares Up 3%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-04-24 11:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Cynata <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (ASX:CYP) said it will act as a core partner in the Solutions for Manufacturing Advanced Regenerative Therapies Cooperative Research Center (SMART CRC), which recently received Australian Government funding, according to a Thursday filing with the Australian bourse.</p><p>SMART CRC is a AU$238 million national initiative with over 60 industry, government, healthcare, universities, and research institute partners, the filing said.</p><p>The partners will now move to draft and execute formal agreements, per the filing.</p><p>Shares were up 3% in afternoon trade on Thursday.</p><p>Price (AUD): $0.20, Change: $+0.0050, Percent Change: +2.63%</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7501","symbol_name":"新冠治療股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2529617985","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2529617985","pubTimestamp":1745466456,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Cynata Therapeutics  said it will act as a core partner in the Solutions for Manufacturing Advanced Regenerative Therapies Cooperative Research Center , which recently received Australian Government funding, according to a Thursday filing with the Australian bourse.SMART CRC is a AU$238 million national initiative with over 60 industry, government, healthcare, universities, and research institute partners, the filing said.The partners will now move to draft and execute formal agreements, per the filing.Shares were up 3% in afternoon trade on Thursday.Price : $0.20, Change: $+0.0050, Percent Change: +2.63%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7501":"新冠治疗股","BK4007":"制药","CYP.AU":"CYNATA THERAPEUTICS LTD","XAO.AU":"标普/澳交所 普通股指数","LENZ":"Therapeutics","XKO.AU":"标普/澳交所 300指数","XJO.AU":"标普/澳交所 200指数","BK4139":"生物科技","BK7067":"生物科技","BK7508":"医药生物股"},"translate_title":"Cynata Therapeutics将成为澳大利亚再生治疗制造计划的核心合作伙伴；股价上涨3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"CYP.AU":0.9,"XKO.AU":1,"XAO.AU":1,"XJO.AU":1},"content_text":"Cynata Therapeutics (ASX:CYP) said it will act as a core partner in the Solutions for Manufacturing Advanced Regenerative Therapies Cooperative Research Center (SMART CRC), which recently received Australian Government funding, according to a Thursday filing with the Australian bourse.SMART CRC is a AU$238 million national initiative with over 60 industry, government, healthcare, universities, and research institute partners, the filing said.The partners will now move to draft and execute formal agreements, per the filing.Shares were up 3% in afternoon trade on Thursday.Price (AUD): $0.20, Change: $+0.0050, Percent Change: +2.63%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}